C4 Therapeutics, Inc. (CCCC) Operating income 2019–2025
C4 Therapeutics, Inc. (CCCC) annual operating income history from SEC filings — each fiscal year as reported.
-$115.2MFY2025 · since FY2019: -$35.5M → -$115.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$115.2M | +3.7% |
| FY2024 | -$119.6M | +14.0% |
| FY2023 | -$139.0M | -7.3% |
| FY2022 | -$129.5M | -57.7% |
| FY2021 | -$82.1M | -35.9% |
| FY2020 | -$60.4M | -70.5% |
| FY2019 | -$35.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice